BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DEMENTIA RESEARCHER - ECPv6.14.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DEMENTIA RESEARCHER
X-ORIGINAL-URL:https://www.dementiaresearcher.nihr.ac.uk
X-WR-CALDESC:Events for DEMENTIA RESEARCHER
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260422
DTEND;VALUE=DATE:20260423
DTSTAMP:20260614T012340
CREATED:20260327T113708Z
LAST-MODIFIED:20260327T113708Z
UID:10002167-1776816000-1776902399@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Replacing in vivo models with complex cellular systems
DESCRIPTION:As regulatory expectations evolve towards inclusion of new approach methodologies (NAMs) in safety assessment and the scientific community focuses on mechanism‑driven discovery research\, this event from ELRIG’s UK Forum offers a timely forum to explore emerging replacement technologies that deliver greater physiological relevance to human biology. \nThrough expert talks\, interactive discussions and technology demonstrations\, attendees will gain a clear understanding of how next‑generation models\, including organoids\, microphysiological systems and co‑culture platforms\, can be integrated into drug discovery pipelines. \nThis one‑day meeting will showcase cutting‑edge advances in complex cellular systems\, animal‑replacement technologies\, and new approach methodologies (NAMs) that are reshaping translational research and reducing reliance on traditional in vivo models. As regulatory expectations evolve and the scientific community accelerates toward human‑relevant\, mechanism‑driven discovery\, the event offers a timely forum for delegates to explore emerging technologies that deliver greater physiological relevance\, improved predictivity\, and enhanced ethical sustainability. Through expert talks\, interactive discussions\, and technology demonstrations\, attendees will gain a clear understanding of how these next‑generation models\, including organoids\, microphysiological systems\, and co‑culture platforms\, can be integrated into discovery pipelines today. \nDelegates will leave with three key learnings: \n\nA critical view of the latest complex cellular\, NAM\, and animal‑replacement systems and their translational value.\nPractical strategies for replacing or reducing animal models while maintaining scientific robustness.\nActionable insights on implementation\, including assay design\, validation considerations\, and operational challenges.\n\nThe programme will deliver: \n\nA critical view of the latest complex cellular models\, NAMs and non-animal technologies and their translational value.\nPractical strategies for replacing or reducing animal models while maintaining scientific robustness.\nActionable insights on implementation\, including assay design\, validation considerations and operational challenges.\n\nAbout ELIRG\nELRIG is a not-for-profit organisation bringing together the global life science and drug discovery industry at open-access\, free-to-attend events. Find out more: elrig.org. \nDr Cathy Vickers (NC3Rs Head of Innovation) is a member of the ELRIG Science Committee and a Director of this ELRIG UK Forum\, alongside Drs Emma Shepard (Aston University)\, Paul Roach (Loughborough University) and Eric Hill (Loughborough University). \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/replacing-in-vivo-models-with-complex-cellular-systems/
LOCATION:Loughborough University\, Epinal Way\, Loughborough\, LE11 3TU\, United Kingdom
CATEGORIES:Training
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/03/ELRIGs-UK-Forum.png
GEO:52.7679306;-1.2227527
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Loughborough University Epinal Way Loughborough LE11 3TU United Kingdom;X-APPLE-RADIUS=500;X-TITLE=Epinal Way:geo:-1.2227527,52.7679306
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260422T090000
DTEND;TZID=Europe/London:20260422T190000
DTSTAMP:20260614T012340
CREATED:20260302T135231Z
LAST-MODIFIED:20260302T135231Z
UID:10002128-1776848400-1776884400@www.dementiaresearcher.nihr.ac.uk
SUMMARY:UCL Advanced Therapies Symposium 2026
DESCRIPTION:The UCL Advanced Therapies Symposium is a flagship event showcasing UCL’s world-leading expertise and multidisciplinary approach to transforming healthcare through advanced therapies. This one-day\, in-person gathering brings together over 250 UCL scientists\, clinical collaborators\, funding bodies\, and industry leaders to explore cutting-edge research and its journey from bench to bedside. \nThe 2026 programme will spotlight CAR-T therapy (autoimmune conditions)\, rare disease gene therapy\, cell therapy and strategies for commercialising innovations from lab to market. Alongside keynote talks and panel discussions\, the symposium will feature talks and poster presentations by early career researchers\, offering fresh perspectives on novel therapeutics and emerging technologies. Delegates will gain insights into UCL’s pioneering work\, clinical applications\, and strategic partnerships\, while networking sessions throughout the day provide invaluable opportunities to connect with experts and foster collaborations across the therapeutic innovation ecosystem. \nCoinciding with UCL’s bicentennial celebrations in 2026—and building on a 200-year legacy of research and innovation—this year’s symposium invites you to explore new collaborations and be part of the effort to advance therapies for the future. \nDate: Wednesday 22 April 2026\nTime: Registration 09.00-9.20; Seminar 9.20-17.30; Networking Reception 17.30-19.00\nOpen to: UCL staff and students\, UCL BRCs*\, and external partners\nVenue: Kennedy Lecture Theatre\, UCL Great Ormond Street Institute of Child Health\, 30 Guilford Street London WC1N 1EH  (Google Map\, Local area map and transportation)\nProvisional agenda: view here \nTickets:\nUCL staff and students; UCL BRCs* – Free registration with UCL email address or designated BRC work email address (If you find that they are currently sold out\, please sign up for the waitlist. We often release more spots as registrants drop out\, so we will notify those on the list as soon as tickets become available.)\nNon-UCL delegates – Early bird offer for £50 (available until 11 March 2026; automatically applied at checkout). Full price: £75;\nNon-UCL academics and public sector – £25\nAll prices are VAT inclusive.\n*UCL BRCs refer to: NIHR UCLH Biomedical Research Centre; NIHR Moorfields Biomedical Research Centre; NIHR Great Ormond Street Hospital Biomedical Research Centre. \nTo stay updated: \nSign up to the mailing list to receive updates about the symposium. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/ucl-advanced-therapies-symposium-2026/
LOCATION:UCL – Kennedy Lecture Theatre\, Institute of Child Health - Main Building\, 30 Guildford Street\, London\, Greater London\, WC1N 1EH\, United Kingdom
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/01/UCL-Logo-2025.png
GEO:51.523309;-0.120066
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=UCL – Kennedy Lecture Theatre Institute of Child Health - Main Building 30 Guildford Street London Greater London WC1N 1EH United Kingdom;X-APPLE-RADIUS=500;X-TITLE=Institute of Child Health - Main Building\, 30 Guildford Street:geo:-0.120066,51.523309
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260422T120000
DTEND;TZID=Europe/London:20260422T124500
DTSTAMP:20260614T012340
CREATED:20260313T103432Z
LAST-MODIFIED:20260423T073821Z
UID:10002151-1776859200-1776861900@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Catch-up - Blood Biomarkers for Alzheimer’s Across Diverse Communities
DESCRIPTION:Can Alzheimer’s disease blood biomarkers work equally well across all populations. And how acceptable are these tests for communities that have historically been under represented in research. \nThis livestream is part of the Dementia Researcher weekly Showcase series. Each week we host a 45 minute online session bringing researchers together to share their work\, methods\, and ideas. \nIn this session\, Natalia Chemas will present research from her NIHR funded doctoral fellowship exploring the diagnostic validity of Alzheimer’s disease blood biomarkers in ethnic minority groups. Her work examines whether these emerging diagnostic tools perform consistently across different populations and explores how acceptable this testing approach is for diverse communities. \nNatalia is a PhD student at Queen Mary University of London working within the dementia research team at the Centre for Psychiatry and Neuroscience. She completed a Psychology BSc in Colombia and a Mental Health Sciences MSc at University College London\, and has experience supporting research studies across academia\, the NHS\, and industry. \nHer doctoral research is supervised by Charles Marshall\, Claudia Cooper\, and Ashvini Keshavan and focuses on improving equitable access to emerging diagnostic approaches in Alzheimer’s disease. \nAttendees can expect a research focused session with time for questions and discussion. \n\nWatch the Recording
URL:https://www.dementiaresearcher.nihr.ac.uk/event/research-showcase-blood-biomarkers-for-alzheimers-across-diverse-communities/
LOCATION:Dementia Researcher Communities App
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/03/Blood-Biomarkers-for-Alzheimers-Across-Diverse-Communities-web.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260422T130000
DTEND;TZID=Europe/London:20260422T150000
DTSTAMP:20260614T012340
CREATED:20260323T110148Z
LAST-MODIFIED:20260323T110148Z
UID:10002155-1776862800-1776870000@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Data Sharing in Dementia Research
DESCRIPTION:Alzheimer Europe Research Insights\, a public webinar series focused on new developments and topics in research. Research Insights are interactive webinars bringing together academic and industry researchers\, clinicians\, national Alzheimer organisations\, policymakers and the wider dementia community\, to exchange knowledge on cross-cutting research topics. Through these\, Alzheimer Europe aims to increase the visibility and impact of European research projects\, support collaboration across consortia\, and raise awareness of research developments in the European dementia community. \nEach session will be hosted on Zoom\, moderated by Alzheimer Europe\, and will combine short presentations from selected projects and initiatives with a panel discussion and audience Q&A. Recordings will be made publicly available afterwards\, via Alzheimer Europe’s YouTube channel. \nOur first Research Insights session will take place on 22 April from 14.00 to 16.00 CET and address the what\, why and how of data sharing in dementia research\, illustrating practical approaches\, platforms and use cases\, alongside perspectives from lived experience. Data sharing can make better use of existing datasets\, support collaboration across disciplines and countries\, and speed up progress in dementia research – but it also raises challenges linked to data protection\, technical barriers and differences in how data are managed. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/data-sharing-in-dementia-research/
LOCATION:Online\, United Kingdom
CATEGORIES:Workshop
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2021/07/Alzheimer-Europe-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260422T140000
DTEND;TZID=Europe/London:20260422T151500
DTSTAMP:20260614T012340
CREATED:20260327T111108Z
LAST-MODIFIED:20260327T111108Z
UID:10002164-1776866400-1776870900@www.dementiaresearcher.nihr.ac.uk
SUMMARY:NAMs Technology Partn3Ring webinar
DESCRIPTION:The first NAMs webinar will include presentations from researchers working across invertebrate models as partial replacements for the use of mammals\, human-relevant microphysiological models\, drug efficacy and drug/consumer product toxicity testing. \nEarly drug screening with C. elegans: A 3Rs-aligned approach \nSara Leighton (Magnitude Biosciences Limited)\n•    High-throughput C. elegans platform\, delivering scalable and predictive insights on drug efficacy\, safety and mechanism of action.\n•    Seeking collaborators to further qualify screening platform and provide access to comparator datasets. \nFrom model to method: Validating C. elegans-based DART assay towards regulatory use \nEva Martini (Nagi Bioscience)\n•    Providing human relevant whole organism toxicity data that can replace early mammalian screens.\n•    Seeking collaborators for new toxicology use cases\, cross‑species comparison\, and standardisation towards regulatory readiness. \nTitle TBC\nMargaret Magdesian (Ananda Devices)\n•    Developing human iPSC‑based neuro and neuromuscular assays towards replacing animal use in neurotoxicity assays.\n•    Seeking partners to benchmark and expand applications\, including exploring incorporation into regulatory workflows. \nTitle TBC\nVitaliy Khutoryanskiy (University of Reading)\n•    Developing invertebrate assays that can replace early-stage mammalian studies in toxicity\, irritation\, infection and formulation screening.\n•    Seeking collaborators interested in co-developing and qualifying the invertebrate-based assays for broader application and increased translational relevance. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/nams-technology-partn3ring-webinar/
LOCATION:Online\, United Kingdom
CATEGORIES:Online
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2023/03/NC3Rs-Logo.png
ORGANIZER;CN="NC3Rs":MAILTO:enquiries@nc3rs.org.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260423T100000
DTEND;TZID=Europe/London:20260423T163000
DTSTAMP:20260614T012340
CREATED:20260220T150019Z
LAST-MODIFIED:20260218T115311Z
UID:10002115-1776938400-1776961800@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Vivensa Foundation 2026 Annual Symposium
DESCRIPTION:Join The Vivensa Foundation to hear about the fantastic initiatives we have been supporting and meet our 2026 Excellence Award winners. \n\n\n\n\nJoin us in-person 10.00-16.30 on Thursday 23rd April 2026 at the the IET in London for our annual symposium.\nOur theme this year is “evidence into practice” and we will also be announcing the winners of this year’s Vivensa Academy Excellence Awards. \nThe event is free to attend**. To register\, the deadline is Monday 6th April 2026. As part of the registration process\, we are offering attendees the opportunity to nominate themselves for a poster presentation and/or a speaking slot in the ‘5-minute research showcase’ section of the agenda. We’ll be reviewing and selecting titles/abstracts to ensure a diverse range of topic areas\, career stages and presenters are represented. The deadline to submit a title and abstract for a poster is 20th March 2026. Given the limited space available for speaking/posters slots\, priority will be given to those from projects funded by the Vivensa Foundation. We will notify all attendees in advance to confirm whether their abstract has been selected for a poster or talk. \nDeadlines: \nTitle/Abstract Submission Deadline: 20th March 2026\nEvent Registration Deadline: 6th April 2026 \nIf you have any questions or need further information\, please don’t hesitate to contact us at admin@vivensafoundation.org.uk \n**We will also aim to cover the costs of travel to the event for early career researchers (ECRs)\, where there is no other means to claim these back. Priority of any available funds will be given to Vivensa Foundation-funded ECRs and/or those selected to present at the event – attendees intending to claim travel costs should confirm these with the Foundation prior to booking travel. If you have any questions about this\, or the event in general\, please email admin@vivensafoundation.org.uk \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/vivensa-foundation-2026-annual-symposium/
LOCATION:IET\, 2 Savoy Place\, London\, WC2R 0B\, United Kingdom
CATEGORIES:Symposium
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/01/Vivensa-Foundation.png
GEO:51.5100099;-0.1192623
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=IET 2 Savoy Place London WC2R 0B United Kingdom;X-APPLE-RADIUS=500;X-TITLE=2 Savoy Place:geo:-0.1192623,51.5100099
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260423T140000
DTEND;TZID=Europe/London:20260423T163000
DTSTAMP:20260614T012340
CREATED:20260409T095603Z
LAST-MODIFIED:20260409T095603Z
UID:10002179-1776952800-1776961800@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Dementia Hub @GIAM: Smell\, Care and Lived Experience
DESCRIPTION:The Dementia Hub @GIAM aims to provide information about dementia to local people\, organisations\, practitioners and businesses in the area. \n\n\n\n\nThe Geller of Institute of Ageing and Memory (GIAM) invites you to attend the second Dementia Hub@GIAM event at the University of West London (UWL). \nThe two speakers are as follows: \nDr Federica D’Andrea\, Senior Lecturer at GIAM\, UWL \nUsing smell in dementia care. Does it work and what’s the evidence? \nThere is growing interest in using smell-based activities in dementia care. Although these approaches are becoming more popular in practice\, there is still limited research showing how effective they are. In this presentation\, Federica will explore how well smell-based interventions work for people living with dementia \nFrank Arrojo\, Former carer for his late mum \nMember of GIAM’s Lived Experience Advisory Panel\, and Organiser of Sudbury & Wembley Dementia Carers Support Groups \nCaring for my mum with dementia: Practical tips and ideas \nFrank will give an insight into what it was like supporting his mum with vascular dementia to live at home\, and some of the lessons he learnt along the way. \nThere will be an opportunity for questions and discussions. This is a free event and everyone is welcome. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/dementia-hub-giam-smell-care-and-lived-experience/
LOCATION:Westmont Enterprise Hub\, Westmont Enterprise Hub University of West London\, 9-10 The Park\, London\, W5 5NE\, United Kingdom
CATEGORIES:Public Discussion
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2019/08/uni-west-london.png
GEO:51.5070664;-0.3024793
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Westmont Enterprise Hub Westmont Enterprise Hub University of West London 9-10 The Park London W5 5NE United Kingdom;X-APPLE-RADIUS=500;X-TITLE=Westmont Enterprise Hub University of West London\, 9-10 The Park:geo:-0.3024793,51.5070664
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260424T110000
DTEND;TZID=Europe/London:20260424T120000
DTSTAMP:20260614T012340
CREATED:20260416T110759Z
LAST-MODIFIED:20260416T110759Z
UID:10002192-1777028400-1777032000@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Professor Iracema Leroi - Dementia research\, treatments and trials updates
DESCRIPTION:What is happening in dementia trials right now\, and what does it mean for research and care? \nJoin Professor Iracema Leroi\, Professor in Geriatric Psychiatry at Trinity College Dublin and Director of the Global Brain Health Institute\, for an overview of current developments in dementia research\, treatments\, and clinical trials. \nIracema leads the Dementia Trials Ireland network and oversees a wide portfolio of drug and non drug clinical trials. Her work spans international collaborations\, including leadership roles in major EU funded programmes. \nIn this session\, she will explore how disease modifying treatments are progressing\, what challenges remain\, and how research is evolving to improve outcomes for people living with dementia. \nAlongside her research leadership\, Iracema is a strong advocate for equitable access to brain health care and for ensuring the voices of people living with dementia shape research\, policy\, and services. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/professor-iracema-leroi-dementia-research-treatments-and-trials-updates/
LOCATION:Online\, United Kingdom
CATEGORIES:Lecture
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2023/07/Dementia-Trials-Ireland.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260424T150000
DTEND;TZID=Europe/London:20260424T160000
DTSTAMP:20260614T012340
CREATED:20260327T121412Z
LAST-MODIFIED:20260327T121412Z
UID:10002169-1777042800-1777046400@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Rethinking ARIA: Antibody Amplified CAA-ri?
DESCRIPTION:Explore new insights into ARIA and CAA in anti amyloid therapies\, examining how antibodies may amplify CAA related inflammation and what this reveals about underlying disease mechanisms – in this webinar organised by the ISTAART Vascular Cognitive Disorders PIA. \nThis session will also highlight emerging biomarker evidence that is reshaping how we interpret the pathophysiology of these conditions and their implications for treatment safety and monitoring. \nBringing together leading expertise\, the discussion will consider how advances in imaging and fluid biomarkers are helping to identify risk\, track progression and better understand patient variability in response to therapy. Expect a focused exploration of how these findings could influence clinical decision making and future therapeutic development. \nSpeakers: Cynthia Lemere\, Fabrizio PiazzaModerators: Beth Eyre\, Roxana Carare \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/rethinking-aria-antibody-amplified-caa-ri/
LOCATION:Online\, United Kingdom
CATEGORIES:Workshop
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2023/01/ISTAART-Logo.png
END:VEVENT
END:VCALENDAR